This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Henrlk Dalbo Slashedge
Introduction
Henrlk Dalbo Slashedge is a notable inventor based in Virum, Denmark. He has made significant contributions to the field of enzymology, particularly through his innovative work on enzymes with endo-1,3(4)-.beta.-glucanase activity. His research has implications for various applications, including biotechnology and pharmaceuticals.
Latest Patents
Henrlk holds a patent for an enzyme characterized by its endo-1,3(4)-.beta.-glucanase activity. The patent describes an enzyme encoded by a specific DNA sequence, which has potential applications in breaking down complex carbohydrates. This innovation showcases his expertise in biochemistry and molecular biology.
Career Highlights
Henrlk is currently employed at Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk emphasizes the importance of research and development in creating effective therapeutic solutions. His contributions to the company reflect his commitment to advancing scientific knowledge and improving health outcomes.
Collaborations
Henrlk has collaborated with esteemed colleagues, including Lene Venke Kofod and Lene Nonboe Andersen. These partnerships highlight the collaborative nature of scientific research, where diverse expertise can lead to groundbreaking innovations.
Conclusion
Henrlk Dalbo Slashedge's work exemplifies the impact of innovative research in the field of enzymology. His patent and contributions to Novo Nordisk demonstrate his dedication to advancing science and improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile